BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 865 filers reported holding BAXTER INTL INC in Q3 2016. The put-call ratio across all filers is 0.50 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $63,934,835 | -26.5% | 1,694,087 | -11.3% | 1.36% | -13.7% |
| Q2 2023 | $87,037,908 | +7.1% | 1,910,402 | -4.6% | 1.58% | +12.5% |
| Q1 2023 | $81,252,320 | +80728.0% | 2,003,262 | +1.6% | 1.40% | -17.6% |
| Q4 2022 | $100,525 | -99.9% | 1,972,243 | +9.4% | 1.70% | -44.7% |
| Q3 2016 | $85,806,000 | +5.8% | 1,802,641 | +0.5% | 3.08% | +4.6% |
| Q2 2016 | $81,140,000 | +20.7% | 1,794,336 | +9.7% | 2.95% | +6.1% |
| Q1 2016 | $67,214,000 | +11.2% | 1,636,178 | +3.3% | 2.78% | +4.1% |
| Q4 2015 | $60,420,000 | +18.4% | 1,583,739 | +1.9% | 2.67% | +9.9% |
| Q3 2015 | $51,046,000 | +34.5% | 1,553,916 | +186.3% | 2.43% | +21.9% |
| Q2 2015 | $37,952,000 | +1.3% | 542,718 | -0.7% | 1.99% | +3.6% |
| Q1 2015 | $37,452,000 | +4.2% | 546,749 | +11.4% | 1.92% | -5.6% |
| Q4 2014 | $35,958,000 | – | 490,623 | – | 2.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |